Generic Modafinil 200 mg

Modafinil 200 mg: Prescription Wakefulness Treatment for Diagnosed Sleep Disorders

Modafinil 200 mg is a prescription wakefulness-promoting medicine for adults with excessive sleepiness associated with narcolepsy, obstructive sleep apnea (OSA), or shift work disorder (SWD). It can improve wakefulness, but it does not cure these conditions, replace sufficient sleep, or treat the airway obstruction that causes OSA. In the United States, modafinil is a Schedule IV controlled substance because it can be misused or lead to dependence.

Important category note: Modafinil is not FDA-approved to treat ADHD, and current labeling states that it is not approved for children for any medical condition, including ADHD. A product page located under an ADHD category should make this distinction clear. Patients seeking ADHD diagnosis or treatment need an appropriate clinical evaluation rather than self-treatment with modafinil.

Only take modafinil after a qualified clinician has diagnosed the cause of excessive sleepiness and reviewed heart health, blood pressure, mental-health history, pregnancy plans, other medicines, and sleep habits. Do not buy modafinil 200 mg without a prescription, use it to compensate for voluntary sleep deprivation, share it, or take more to extend working or study time. Persistent sleepiness can make driving unsafe even when medication is used.

What Is in a 200 mg Modafinil Tablet?

Each tablet contains 200 mg of modafinil as the active ingredient. Provigil is a well-known brand name; several FDA-approved generics are available. Tablet color, shape, score line, imprint, and inactive ingredients vary by manufacturer. One current label describes a white-to-off-white, round, uncoated, scored tablet, while other legitimate products may look different.

A changed appearance is not automatically a dispensing error, but it should be verified before use. Compare the medication name, strength, manufacturer, and imprint on the bottle, then ask the pharmacist about any difference. Never use a pill purchased from a marketplace or identified only through an image. Counterfeit controlled medicines may contain the wrong drug, an inaccurate amount, or harmful contaminants.

The 200 mg strength is the labeled recommended daily dose for many adults with narcolepsy or OSA and for adults with SWD, but timing differs by condition. That general fact is not permission to start, repeat, split, or increase a dose without a prescription. Severe liver impairment and older age may require lower exposure or closer monitoring.

Three Approved Uses, Three Different Treatment Contexts

Narcolepsy

Narcolepsy is a chronic neurologic sleep disorder that can cause overwhelming daytime sleepiness and unintended sleep episodes. Some patients also have cataplexy, sleep paralysis, disrupted nighttime sleep, or vivid sleep-related hallucinations. Diagnosis usually requires a sleep specialist’s history and objective testing after other explanations are considered.

Modafinil may improve wakefulness, but it does not treat every narcolepsy symptom and does not remove the need for scheduled sleep, safety planning, or other prescribed therapies. A patient may remain sleepy enough that driving or hazardous work is unsafe. Follow-up should assess real-world alertness, not simply whether the patient feels more productive.

Obstructive sleep apnea

OSA repeatedly narrows or closes the upper airway during sleep. It can produce loud snoring, witnessed breathing pauses, fragmented sleep, morning headache, poor concentration, cardiovascular strain, and daytime sleepiness. Modafinil treats residual excessive sleepiness in selected adults; it does not open the airway.

If continuous positive airway pressure (CPAP) or another airway treatment is prescribed, it should be optimized and continued. Before adding modafinil, clinicians typically examine treatment adherence, mask leak, sleep duration, other sedating medicines, depression, restless legs, circadian factors, and other causes of fatigue. Taking a wake-promoting tablet while abandoning CPAP leaves the underlying disease untreated.

Shift work disorder

SWD involves insomnia and/or excessive sleepiness related to a work schedule that overlaps the usual sleep period. It is not the same as ordinary tiredness after an occasional late night. Evaluation considers schedule history, sleep opportunity, duration of symptoms, other sleep disorders, substance use, and whether the person can obtain adequate protected sleep.

For diagnosed SWD, current labeling places the 200 mg dose approximately one hour before the work shift. A prescriber may still decide that a different plan is safer for an individual. Modafinil does not make unlimited wakefulness safe and cannot prevent every error, microsleep, or drowsy-driving event.

What Modafinil Does—and Does Not Do

The exact mechanism through which modafinil promotes wakefulness is not fully established. It affects central nervous system signaling and shares some effects with stimulant medicines, although its pharmacology is not identical to amphetamine. Its clinical purpose is to improve wakefulness in the approved sleep-disorder contexts.

Modafinil does not:

• Replace adequate sleep or repair accumulated sleep debt
• Cure narcolepsy, OSA, or shift work disorder
• Treat the airway obstruction in OSA
• Guarantee safe driving or safe operation of machinery
• Provide approved treatment for ADHD, depression, general fatigue, or cognitive enhancement
• Make an all-night work, gaming, travel, or study schedule medically safe

Feeling more awake can sometimes mask the degree of physiologic sleep loss. Patients should continue to follow sleep-scheduling and workplace-safety advice, and they should report unplanned sleep, near-miss accidents, or drowsiness while driving.

How a Clinician Evaluates Excessive Sleepiness

“I am tired” can describe sleepiness, fatigue, low motivation, breathlessness, weakness, depression, medication sedation, or an endocrine or blood disorder. Modafinil is not a universal answer to these symptoms. A focused evaluation may include:

• Typical sleep and wake times on workdays and free days
• Total sleep opportunity, naps, insomnia, and schedule variability
• Snoring, gasping, witnessed apnea, restless legs, or unusual sleep behaviors
• Unintended sleep while reading, talking, eating, working, or driving
• Current medicines, alcohol, cannabis, caffeine, nicotine, and other substances
• Depression, mania, psychosis, anxiety, and other mental-health symptoms
• Blood pressure, cardiovascular history, body weight, and relevant laboratory testing
• Sleep-study or multiple-sleep-latency-test results when clinically indicated

A patient should not exaggerate symptoms to obtain a prescription or minimize dangerous driving. Accurate details help distinguish an approved use from another condition needing different treatment.

How to Take a Prescribed Modafinil 200 mg Dose

Take the medicine exactly as written on the prescription. For narcolepsy or OSA, current labeling recommends 200 mg once in the morning. For SWD, it recommends 200 mg approximately one hour before the shift. The prescriber may modify the plan for liver impairment, older age, interactions, or adverse effects.

Modafinil can be taken with or without food. Food may delay the time to peak concentration, so use a consistent approach if the prescriber recommends it. Taking the medicine too close to the planned sleep period may worsen insomnia. Do not take an extra tablet because the effect seems delayed, and do not redose during a long shift unless specifically prescribed.

Doses up to 400 mg per day have been studied, but current labeling notes no consistent evidence of added benefit beyond 200 mg per day for narcolepsy or OSA. Higher exposure may increase dose-related headache and anxiety. “More wakefulness” is not a safe self-directed treatment target.

Missed Dose and Schedule Changes

If a dose is missed, contact the prescriber or pharmacist when the correct action is unclear. Taking it late can interfere with the next sleep period. Do not take two doses together to make up for one missed dose.

Rotating shifts, travel across time zones, daylight-saving changes, or a move from night work to day work can make the original timing inappropriate. Ask for a schedule-specific plan rather than moving the dose by guesswork. A refill label cannot account automatically for a changed work pattern.

The Rash Warning Every Patient Must Know

Rare serious or life-threatening skin reactions have been reported with modafinil, including Stevens-Johnson syndrome, toxic epidermal necrolysis, and drug reaction with eosinophilia and systemic symptoms (DRESS). It is not possible to reliably predict which early rash will remain mild. Most reported serious rashes have appeared relatively early, but delayed cases have occurred.

Stop taking modafinil and seek immediate medical advice at the first sign of a rash unless a clinician clearly determines that it is unrelated. Emergency features include blistering or peeling skin, sores in the mouth, hives, facial swelling, swollen lymph nodes, fever, difficulty breathing or swallowing, yellowing of the skin or eyes, dark urine, or symptoms affecting multiple organs.

Do not take another dose to “see whether it happens again.” Rechallenge can be dangerous. A prior allergic reaction or rash to modafinil or armodafinil should be disclosed before any prescription.

Psychiatric Effects and Mood Monitoring

Anxiety, nervousness, insomnia, and agitation can occur. Postmarketing reports have also included mania, delusions, hallucinations, suicidal thoughts, and aggression, sometimes requiring hospitalization. Risk assessment is particularly important for patients with a history of psychosis, bipolar disorder, depression, or suicidal behavior.

Contact the prescriber promptly for unusual irritability, racing thoughts, markedly reduced need for sleep, impulsive behavior, paranoia, hallucinations, or worsening depression. Suicidal thoughts, dangerous aggression, severe confusion, or inability to care for oneself require urgent or emergency help. Family members may notice changes before the patient does and should know how to reach the treatment team.

Heart Rate, Blood Pressure, and Chest Symptoms

Modafinil can affect cardiovascular function. Current labeling recommends caution in people with known cardiovascular disease and increased monitoring in some patients. Blood-pressure and heart-rate checks may be appropriate, especially after starting or changing the dose.

Tell the prescriber about high blood pressure, recent heart attack, unstable angina, arrhythmia, fainting, mitral valve prolapse symptoms associated with stimulants, or left ventricular hypertrophy. Seek urgent evaluation for chest pain, fainting, new shortness of breath, or a sustained rapid or irregular heartbeat.

Do not combine modafinil with large amounts of caffeine, stimulant supplements, or another stimulant without medical review. A supplement label may hide caffeine under ingredients such as guarana, yerba mate, or “energy blend.”

Common Side Effects

In pooled placebo-controlled trials, common adverse reactions included headache, nausea, nervousness, nasal symptoms, diarrhea, back pain, anxiety, insomnia, dizziness, and indigestion. Dry mouth, reduced appetite, chest discomfort, palpitations, and elevated blood pressure can also occur.

Keep a brief record of dose timing, food, caffeine, sleep, and symptoms during the first weeks. This can help the clinician distinguish a medicine effect from inadequate sleep or another condition. Do not treat insomnia with alcohol or a borrowed sedative. That can create a dangerous cycle of a wake-promoting medicine followed by a depressant.

Hormonal Contraception Interaction

Modafinil can increase the clearance of steroidal contraceptives and reduce their effectiveness. Current labeling recommends an alternative or additional contraceptive method during treatment and for one month after modafinil is stopped. This concern can apply to pills, patches, rings, injections, implants, and some hormonal intrauterine products; the patient should review the exact method with a clinician.

Do not rely on simply taking the contraceptive at a different time of day. Discuss a suitable non-hormonal or additional method before starting modafinil. If pregnancy occurs or is suspected, contact the prescriber promptly.

Other Clinically Important Interactions

Modafinil can induce CYP3A4/5 and inhibit CYP2C19, changing exposure to other medicines. The medication review should include:

• Cyclosporine: concentrations may fall, which can be clinically serious for a transplant recipient.
• Diazepam, phenytoin, omeprazole, propranolol, and clomipramine: exposure may increase in some patients.
• Warfarin: more frequent INR or prothrombin-time monitoring may be considered.
• MAO inhibitors: concurrent use requires caution and prescriber review.
• Steroidal contraceptives: effectiveness may be reduced during treatment and for one month afterward.
• Other stimulants or wake-promoting medicines: may add cardiovascular, anxiety, and insomnia effects.

This is not a complete list. Show the pharmacist every prescription, over-the-counter medicine, vitamin, herb, and supplement. Do not start a new medicine without checking for interactions.

Pregnancy and Breastfeeding

Current labeling states that modafinil may cause fetal harm based on animal data, and reports have included intrauterine growth restriction and spontaneous abortion, although causation in reported human cases may be uncertain. Anyone who is pregnant, may be pregnant, or plans pregnancy should discuss benefits, risks, and alternatives before use.

Because modafinil can reduce hormonal contraceptive effectiveness, pregnancy planning must include the interaction period after stopping. Breastfeeding also requires individualized advice because product transfer and infant risk must be considered alongside the parent’s need for treatment and the availability of alternatives.

Older Adults and Liver or Kidney Conditions

For severe hepatic impairment, current labeling recommends reducing the modafinil dose to one-half of the usual recommended amount. Older adults may clear the medicine more slowly and may need lower doses and closer monitoring. A patient should not create a half-dose plan by splitting a tablet unless the prescriber and pharmacist approve the exact product and technique.

Severe kidney impairment may increase exposure to an inactive metabolite even if modafinil pharmacokinetics are less affected. Tell the prescriber about kidney disease and all relevant laboratory results. Changes in liver or kidney health after a prescription is established should prompt review.

Driving and Safety-Sensitive Work

Modafinil may improve wakefulness without restoring it to normal. Patients may underestimate remaining sleepiness, especially during monotonous driving, early-morning hours, or long shifts. The prescriber should reassess real-world sleepiness regularly.

Do not drive or operate dangerous machinery until the effect is known. Stop driving and arrange safe transportation after a microsleep, lane drift, missed exit, near collision, or inability to remember part of a journey. Medication is not permission to ignore workplace hour limits or fatigue policies.

Misuse, Dependence, and Controlled-Drug Responsibilities

Modafinil can produce psychoactive and stimulant-like effects and has been misused for productivity, gaming, studying, weight loss, and extended wakefulness. Taking it against medical advice, increasing the amount, obtaining prescriptions from multiple clinicians, or buying tablets from unverified sellers can indicate misuse.

Store it securely, do not share it, and keep track of the dispensed quantity. Selling or giving away a Schedule IV medicine is unlawful. Tell the prescriber about any history of alcohol, prescription-drug, or street-drug misuse. That information supports safer monitoring; it should not be hidden.

Safe Online Purchase: What “Prescription Modafinil” Should Mean

Patients often search for “buy modafinil 200 mg online,” “generic Provigil 200 mg price,” “modafinil prescription delivery,” or “order modafinil tablets.” The safe transaction sequence is diagnosis, prescription, pharmacy verification, pharmacist counseling, and traceable dispensing. A seller should never be the person deciding whether the drug is appropriate.

A legitimate online pharmacy should:

• Require a valid prescription from a licensed clinician
• Be licensed by the state board of pharmacy where the patient receives medicine
• Provide a verifiable U.S. physical address and phone number
• Make a licensed pharmacist available
• Dispense the exact prescribed strength in sealed, patient-labeled packaging
• Provide a Medication Guide and manufacturer or distributor information
• Avoid “no prescription,” “smart drug,” “study pill,” and bulk-quantity promotions

Extremely low modafinil prices, cryptocurrency-only payment, worldwide controlled-drug shipping, social-media ordering, and guaranteed delivery without prescription verification are red flags. Search ranking and customer testimonials do not establish a pharmacy license. Check the license independently.

Comparing Brand Provigil and Generic Modafinil

FDA-approved generic medicines must meet applicable standards for quality and bioequivalence. The active ingredient and strength should match the prescription, while inactive ingredients and appearance may differ. Cost can vary by insurance, pharmacy, quantity, manufacturer, and discount arrangements.

Do not pay more solely because a seller claims a product is “European,” “pharmacy grade,” or “original Provigil” without a traceable licensed supply chain. Conversely, do not assume every inexpensive tablet is a legitimate generic. The dispensing pharmacy’s license and the labeled manufacturer matter more than marketing language.

A Two-Week Wakefulness and Sleep Log

A short diary can make follow-up more useful and reduce pressure to adjust the dose based on one unusually good or bad day. Record the following each day:

• Bedtime, estimated sleep onset, awakenings, final wake time, and naps
• CPAP or other OSA-treatment use, including mask problems or nights skipped
• Work-shift start and end times
• Exact modafinil dose time and whether it was taken with food
• Caffeine, alcohol, cannabis, nicotine, and other potentially alerting or sedating substances
• Unplanned sleep, microsleeps, near-miss accidents, or drowsy driving
• Headache, nausea, anxiety, palpitations, rash, insomnia, and mood changes

The goal is not to prove that a prescription “works” but to show the relationship among sleep opportunity, underlying treatment, dose timing, and safety. A patient whose log shows only five hours of sleep most nights may need schedule protection more than a higher amount. A CPAP user with persistent mask leak may need equipment support. Someone with sudden new sleepiness despite good sleep and adherence may need assessment for another condition.

Bring the log to the prescriber; do not use it to self-titrate. Seek help immediately rather than waiting for the next appointment if the record includes a rash, hallucinations, suicidal thoughts, chest pain, fainting, or dangerous driving events.

Caffeine, Energy Products, and the “Stacking” Problem

Patients sometimes add coffee, energy drinks, pre-workout powders, nicotine, decongestants, or another stimulant when 200 mg seems insufficient. Combining alerting substances can worsen anxiety, tremor, insomnia, rapid heartbeat, and blood pressure. The total stimulant burden may be hard to recognize because supplement labels use proprietary blends.

Tell the prescriber the actual number and size of caffeinated drinks, not simply “some coffee.” Check labels for caffeine, guarana, yerba mate, kola nut, synephrine, yohimbe, and other stimulating ingredients. Avoid changing several variables at once; otherwise, the cause of a side effect becomes unclear.

A late-day stimulant may delay sleep, leading to greater next-day sleepiness and another dose or more caffeine. This wake-sleep cycle can make the medicine appear less effective over time even when poor sleep timing is the main problem. A clinician or sleep specialist can help plan caffeine limits, light exposure, naps, and protected sleep for the diagnosed condition.

Counterfeit Modafinil: Why Visual Checks Are Not Enough

Tablets sold as “Moda 200,” “Provigil,” “Modafinil 200,” or a named overseas brand may come from an unverified supply chain. A professional blister pack, QR code, hologram, or laboratory certificate posted by the seller does not prove that the delivered batch matches the image. The tablet could contain too much, too little, no modafinil, or a different active drug.

Counterfeit risk is especially important when a website bypasses a prescription or offers bulk tablets for cognitive enhancement. The buyer has no pharmacist checking allergies, contraceptive interactions, cardiovascular history, or psychiatric symptoms. If the product causes a rash or overdose, the package may not provide reliable ingredients or manufacturer contact information to emergency clinicians.

Do not “test” a questionable tablet by taking a fraction. Unevenly distributed ingredients can make a fragment misleading. Keep the package away from others and ask a pharmacist or regulator about disposal. After accidental ingestion or symptoms, contact Poison Control or emergency care and provide all available packaging.

Off-Label Use Questions Belong With a Clinician

Clinicians sometimes prescribe approved medicines for uses not listed in the FDA indication when they judge that evidence and patient circumstances support it. That professional practice is different from a seller advertising modafinil for depression, multiple sclerosis fatigue, jet lag, long COVID, weight loss, ADHD, or “brain enhancement” to anyone who clicks buy.

An off-label decision should still include a diagnosis, alternatives, informed discussion, monitoring, and a lawful prescription. The patient should ask what evidence supports the use, how benefit will be measured, how long a trial will last, and which result will lead to stopping. An online review or productivity testimonial cannot answer those questions.

For ADHD in particular, sleep deprivation and untreated sleep disorders can mimic inattention. Conversely, ADHD can coexist with narcolepsy or OSA. A careful clinician separates symptoms, age of onset, impairment across settings, sleep-study findings, and mood or substance-use factors before selecting treatment. Using modafinil without that assessment can delay the correct diagnosis.

Refill Review: When Continuing 200 mg Deserves Reassessment

A refill should not be automatic if the patient has developed a rash, pregnancy, uncontrolled hypertension, new cardiac symptoms, mania, psychosis, suicidal thoughts, misuse, or a major interaction. Continued treatment also deserves review when sleepiness remains dangerous, CPAP has been abandoned, the work schedule has changed, or the patient repeatedly uses extra tablets.

On the other hand, stable benefit does not justify sharing tablets or skipping follow-up. Controlled-drug monitoring, blood-pressure checks, sleep-disorder treatment, and updated medication review remain relevant. The safest long-term plan uses the lowest effective prescribed exposure while continuing to address the cause of sleepiness.

What a Good Product Page Should Not Promise

Responsible modafinil content should not promise guaranteed focus, all-day energy, exam success, weight loss, “limitless” cognition, or safe sleep deprivation. It should not claim that 200 mg works for everyone, is non-addictive, has no withdrawal or misuse risk, or is safer than every stimulant. Claims such as “no doctor required” and “100% side-effect free” are particularly unsafe.

Transactional content can instead help a legitimate patient complete a safe prescription journey: understand the approved uses, compare a prescribed generic price, verify an online pharmacy, check interactions, and know when to contact the clinician. That information serves purchase intent without turning a controlled medicine into a consumer productivity product.

Frequently Asked Questions About Modafinil 200 mg

Is modafinil 200 mg approved for ADHD?

No. Its U.S. approved uses are excessive sleepiness associated with narcolepsy, OSA, and SWD in adults. It is not approved for pediatric use or for ADHD. An ADHD evaluation should consider symptoms across settings, developmental history, sleep, mood, and other causes.

Is modafinil a stimulant?

It is described as a wakefulness-promoting agent and has stimulant-like central nervous system effects. It is federally controlled in Schedule IV. “Not an amphetamine” does not mean non-controlled or free of misuse risk.

How long does a 200 mg tablet last?

The clinical duration varies with metabolism, liver function, age, food timing, other medicines, and sleep pressure. Do not use a predicted number of hours to schedule unsafe driving or redose. Follow the prescribed timing.

Can I take it only when I need to study?

No. It should be used only for the diagnosed condition and prescribed schedule. Using it as a study drug can worsen insomnia, anxiety, cardiovascular symptoms, and misuse risk while masking sleep deprivation.

Can modafinil replace CPAP?

No. It treats residual sleepiness, not the airway obstruction. Continue CPAP or the prescribed OSA treatment and discuss adherence problems with the sleep team.

What should I do if I develop a rash?

Stop the medicine and seek immediate medical advice unless a clinician clearly determines that it is unrelated. Blisters, mouth sores, peeling, fever, facial swelling, breathing difficulty, or organ-related symptoms need urgent help.

Can modafinil reduce birth-control effectiveness?

Yes. It may reduce the effectiveness of steroidal contraceptives during treatment and for one month after stopping. Arrange an alternative or additional method with a clinician.

Is 400 mg better than 200 mg?

Not necessarily. Labeling notes no consistent additional benefit beyond 200 mg per day for narcolepsy or OSA, while headache and anxiety may be dose-related. Never increase the amount yourself.

Can I drink alcohol?

The combination has not been adequately studied, and labeling advises that avoiding alcohol is prudent. Alcohol can also worsen sleep quality and impair judgment.

Why am I still sleepy?

The underlying disorder may be incompletely treated, sleep duration may be inadequate, another medicine may be sedating, or another condition may be present. Stop hazardous activities and contact the clinician rather than taking extra modafinil.

Can I buy modafinil 200 mg online without a prescription?

No legitimate U.S. pharmacy should dispense it without a valid prescription. Unverified sites may sell counterfeit or incorrectly dosed tablets and expose buyers to financial and legal risk.

What if the tablet imprint is different?

Do not take it until the dispensing pharmacist confirms the manufacturer and product. Generic appearance can change, but every legitimate change should be traceable through the pharmacy label.

Can modafinil help ordinary fatigue?

Fatigue has many causes and is not automatically an approved indication. Anemia, thyroid disease, infection, heart or lung disease, depression, medication effects, and inadequate sleep may need evaluation and different treatment.

What are overdose symptoms?

Reported symptoms include insomnia, agitation, restlessness, confusion, disorientation, hallucinations, nausea, diarrhea, fast or slow heartbeat, chest pain, and increased blood pressure. Go to an emergency department or contact emergency services after an overdose.

Patient Takeaway

Modafinil 200 mg is a prescription wakefulness medicine for diagnosed narcolepsy, residual sleepiness associated with treated OSA, or shift work disorder. It is not an ADHD or general productivity drug. Safe use requires correct diagnosis, condition-specific timing, continued OSA therapy when applicable, monitoring for rash and psychiatric or cardiovascular effects, attention to contraception and drug interactions, responsible controlled-drug storage, and purchase only through a licensed pharmacy with a valid prescription.

Medical References Reviewed

• DailyMed modafinil tablet prescribing information and Medication Guide: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=60ec6e2a-2576-498f-9a8c-fddc53d4a44c
• FDA BeSafeRx pharmacy-safety checklist: https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/considering-online-pharmacy
• FDA guide to locating a state-licensed online pharmacy: https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy